Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of ...

Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring ...

BMO senior economist Sal Guatieri points out the severe negative effects of the trade war on industrial investment, ...

AUSTIN, Texas and TOKYO, Sept. 18, 2025 /PRNewswire/ — According to DataM Intelligence, the global AI in remote patient ...

DexCom, Inc. ( NASDAQ: DXCM) Baird Global Healthcare Conference 2025 September 10, 2025 2:00 PM EDT Next presentation this afternoon is from DexCom, a leader in developing and commercializing ...

According to DataM Intelligence, the global AI in remote patient monitoring market reached US$ 5.45 billion in 2023, with a rise to US$ ...

The Dow Jones Industrial Average joined other indexes higher after surprise weekly jobless claims. Nvidia stock jumps on its ...

Wall Street closed higher Friday, marking its third straight weekly gain, after the Federal Reserve delivered a long-awaited 25 basis-point rate cut—the first in nine months. The Fed’s updated ...

The FDA identified a recall of smartphone apps for Dexcom (Nasdaq:DXCM) continuous glucose monitors as the most serious type.

SEATTLE--(BUSINESS WIRE)--Veeam ® Software, the #1 global leader by market share in Data Resilience, today announced the availability of its first fully pre-built, pre-hardened software appliance: the ...

New Veeam Software Appliance empowers IT teams to achieve instant protection with Veeam’s fully preconfigured, software-only appliance, delivering enterprise-ready simplified deployment and ...

SAN DIEGO, August 26, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences: The 2025 ...